Published: 2019-11-26

Spot protein/creatinine ratio as a marker for fetomaternal outcome in hypertensive disorder of pregnancy

Ashima Taneja, Gagandeep Kaur, Manpreet Kaur, Muskan Chaudhary, Kulvir Kaur


Background: Gestational hypertension is defined as systolic BP level of > 140 mmHg or a diastolic BP of > 90 mmHg that occur after 20 weeks of gestation. Pre-eclampsia is the hypertensive disorder of pregnancy, associated with adverse fetomaternal complications. It is assosciated with proteinuria. 24 hours urine collection is cumbersome, time consuming and potentially misleading if collected inaccurately. The spot P/C ratio has been considered equivalent to 24-hour urinary protein for predicting proteinuria. Aim of study was to compare spot P/C ratio to 24 hours urinary protein in patients of pre-eclampsia and to determine the fetomaternal outcome in the patients admitted in Dayanand Medical College and Hospital, Ludhiana.

Methods: A prospective simple random study. It included 100 hypertensive pregnant women being evaluated for pre-elampsia, regardless of the alerting signs or symptoms. The main measures were the urinalysis of patients which included urinary spot P/C and 24 hours urinary protein excretion and the fetomaternal outcome in these patients. The data was statistically analyzed.

Results: A good positive correlation existed between the P/C ratio and 24 hours protein excretion, with a correlation coefficient (r) of 0.912. The sensitivity and specificity of 24 hours urinary protein versus spot P/C ratio ranged between 86.29%-99.51% and 8.35%-99.95% respectively. The positive and negative likelihood ratio of 24 hours urinary protein versus spot P/C ratio was 48 (ranged between 6.89-334) and 0.04 (ranged between 0.01-0.16) respectively. The positive and negative predictive value of 24 hours urinary protein versus spot P/C ratio was 97.96% and 96.08% respectively. Our data showed that urine spot P/C ratio above 3.9/mg strongly predicts significant proteinuria of more than 4 gram/day.

Conclusions: Spot urinary P/C ratio with suspected preeclampsia can be used as a rapid alternative test to 24 hours urinary protein.


Gestational hypertension, Pre-eclampsia, Proteinuria, Spot P/C ratio, Urinalysis, 24 hours urinary protein

Full Text:



Report of the National high blood pressure education-program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.

Fukui A, Yokota M, Funamizu A, Nakamua R, Fukuhara R, Yamada K, et al. Changes of NK cells in preeclampsia. Am J Reprod Immunol. 2012;67:278-86.

Nelissen EC, van Montfoort AP, Dumoulin JC, Evers JL. Epigenetics and the placenta. Hum Reprod Update. 2011;17:397-417.

Pijnenborg R, Vercruysse L, Hanssens M. Fetal-maternal conflict, trophoblast invasion, preeclampsia, and the red queen. Hypertens Preg. 2008;27:183-96.

Adeyinka DA, Oladimeji O, Adekanbi TI, Adeyin-ka FE, Falope Y, Aimakhu C. Outcome of adolescent pregnancies in southwestern Nigeria: a case-control study. J Matern Fetal Neonatal Med. 2010;23(8):785-9.

Assis TR, Viana FP, Rassi S. Study on the major maternal risk factors in hypertensive syndromes. Arq Bras Cardiol. 2008;91(1):11-7.

Ramesh K, Gandhi S, Rao V. Socio-demographic and other risk factors of pre-eclampsia at a tertiary care hospital, Karnataka: case control study. J Clin Diagn Res. 2014;8(9):JC01-JC04.

Bdolah Y, Elchalal U, Natanson-Yaron S, Yechiam H, Bdolah-Abram T, Greenfield C, et al. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase. Hyper Preg. 2014;33(2):250-9.

Facchinetti F, Allais G, D'Amico R, Benedetto C, Volpe A. The relationship between headache and preeclampsia: a case-control study. Eur J Obstet Gynecol Reprod Biol. 2005;121(2):143-8.

Sunness JS. The pregnant woman’s eye. Surv Ophthalmol. 1988;32:219-38.

Steinberg G, Khankin EV, Karumanchi SA. Angiogenic factors and preeclampsia. Thromb Res. 2012;123(Suppl 2):S93-99.

Nischintha S, Pallavee P, Ghose S. Correlation between 24-h urine protein, spot urine protein/creatinine ratio, and serum uric acid and their association with fetomaternal outcomes in preeclamptic women. J Nat Sci Biol Med. 2014;5(2):255-60.

Ngwenya S. Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe. Int J Womens Health. 2017;9:353-7.

Jan S, Javaid C, Firdous N. Diagnostic accuracy of spot urinary protein/creatinine ratio for proteinurea in pregnancy induced hypertension. Int J Reprod Contracept Obstet Gynecol. 2017;6(5):2083-9.

Kishwara, Tanira S, Omar E, Wazed F, Ara S. Effects of preeclampsia on perinatal outcome- a study done in the specialized urban hospital set up in Bangladesh. Bang Med J. 2016;40(1):33.

Montero N, Soler MJ, Pascual MJ, Barrios C, Márquez E, Rodríguez E, et al. Correlation between the protein/creatinine ratio in spot urine and 24-hour urine protein. Nefrol. 2012;32(4):494-501.

Demirci O, Kumru P, Arınkan A. Spot protein/creatinine ratio in preeclampsia as an alternative for 24-hour urine protein. Balkan Med J. 2015;32(1):51-5.

Martins-Costa SH, Vettorazzi J, Valerio E, Maurmman C, Benevides G, Hemessath M, et al. Protein creatinine ratio in random urine sample of hypertensive pregnant women: Maternal and perinatal outcomes. Hyper Preg. 2011;30:331-7.